Argonaute RNA Ltd
New Form D on file · 2026-09-24 · the record
What the record says
Trailing twelve months. 759 filings in Biotechnology, totalled by week. The dot is this raise, $1.80M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Company officers on record
Anthony Parker is named as Executive Officer and Director on the Form D that Argonaute RNA Ltd filed with the SEC on 24 September 2026, one of 9 people that filing names.
Michael Khan is named as Executive Officer and Director on the Form D that Argonaute RNA Ltd filed with the SEC on 24 September 2026, one of 9 people that filing names.
Richard Tompkins is named as Director on the Form D that Argonaute RNA Ltd filed with the SEC on 24 September 2026, one of 9 people that filing names.
Johnathan Matlock is named as Director on the Form D that Argonaute RNA Ltd filed with the SEC on 24 September 2026, one of 9 people that filing names.
David Ball is named as Director on the Form D that Argonaute RNA Ltd filed with the SEC on 24 September 2026, one of 9 people that filing names.
Alexander Fink is named as Director on the Form D that Argonaute RNA Ltd filed with the SEC on 24 September 2026, one of 9 people that filing names.
Ross Burn is named as Director on the Form D that Argonaute RNA Ltd filed with the SEC on 24 September 2026, one of 9 people that filing names.
Nabil Al-Chalaby is named as Director on the Form D that Argonaute RNA Ltd filed with the SEC on 24 September 2026, one of 9 people that filing names.
Nigel Davis is named as Director on the Form D that Argonaute RNA Ltd filed with the SEC on 24 September 2026, one of 9 people that filing names.
9 people named on the filing — 2 holding an executive role and 7 as directors only.
Named as of the 2026-09-24 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
- 9 people named on the filing — 2 holding an executive role and 7 as directors only.
No investor is drawn from a Form D — the form states how many invested and never who.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Argonaute RNA Ltd
- Source Check — verify Peter Nowell's other claims against the registers that hold them.
- INVEST — size up this raise on the figures the filing states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Peter Nowell for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Argonaute RNA LtdYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Argonaute RNA Ltd: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. FoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.